论文部分内容阅读
目的观察弥可保联合法舒地尔治疗糖尿病周围神经病变的临床疗效。方法将60例患者随机分为治疗组和对照组,每组30例,两组患者在治疗时间、降糖药物及饮食与治疗前保持不变,治疗组给予弥可保联合法舒地尔治疗,对照组给予弥可保治疗,两组疗程均为4周。结果治疗组糖尿病周围神经病变症状、体征、神经传导速度明显高于对照组。结论弥可保联合法舒地尔治疗糖尿病周围神经病变疗效显著。
Objective To observe the clinical efficacy of methycobal combined with fasudil in the treatment of diabetic peripheral neuropathy. Methods Sixty patients were randomly divided into treatment group and control group, with 30 cases in each group. The two groups remained unchanged before treatment, hypoglycemic drugs and diet and before treatment. The treatment group was treated with methyclopril combined fasudil , The control group was given Mi Kebao treatment, two courses of treatment were 4 weeks. Results The symptoms, signs and nerve conduction velocity of diabetic peripheral neuropathy in treatment group were significantly higher than those in control group. Conclusion Miqibao combined Fasudil treatment of diabetic peripheral neuropathy significant effect.